RLI Corp. <RLI.N>: Wells Fargo cuts to underweight from equal weight
RLI•Related News
Accendra Health Q2 profit, revenue miss estimates on large payor exit
ACH•
Quantum BioPharma wins FDA IND clearance for Lucid-MS Phase 2 trial in progressive MS
QNTM•
Palladyne AI names retired Maj. Gen. Mark A. Clark to defense advisory board
PDYN•
Strategy <MSTR.O>: Mizuho cuts target price to $165 from $213
MSTR•
ATI: Deutsche Bank raises target price to $262 from $231
ATI•